EBF1 downregulation has been described to be a diagnostic marker in CLL50, and its low expression may lead to reduced levels of numerous B cell signaling factors contributing to the anergic signature of CLL cells51,52 and low susceptibility to host immunorecognition53,54. The gene discussed is EBF1; the disease is B-cell chronic lymphocytic leukemia.